Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1996
10/08/1996US5562920 Elongated, divisible tablet
10/08/1996US5562919 Dried animal plasma as a pharmaceutical excipient for compressed tablet formulation
10/08/1996US5562917 Includes water soluble methyl cellulose-type gel, and water
10/08/1996US5562915 Sustained release capsule and formulations
10/08/1996US5562913 Formulation for use in smokers
10/08/1996US5562911 Cosmetics
10/08/1996US5562909 Phosphazene polyelectrolytes as immunoadjuvants
10/08/1996US5562908 Treatment of sinus headache
10/08/1996US5562654 Time-released delivery system
10/08/1996US5562653 Polymeric implants which can depolymerize within human or animal bodies by mild heating or treatment with nontoxic chemicals for noninvasive removal
10/08/1996US5562642 Separately packaged applicator pads for topical delivery of incompatible drugs
10/08/1996US5562608 Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
10/08/1996US5562099 Polymeric microparticles containing agents for imaging
10/08/1996CA2072460C Use of acid derivatives for pediculicidal medicament production
10/07/1996CA2146481A1 Method for immunization of mammals against atherosclerosis and pharmaceutical compositions for obtaining said immunization
10/03/1996WO1996030385A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996WO1996030068A1 Intrapulmonary delivery of hematopoietic drug
10/03/1996WO1996030051A1 Use of surfactants for introducing genetic material into lung cells
10/03/1996WO1996030036A1 Compounds and compositions for delivering active agents
10/03/1996WO1996030028A2 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
10/03/1996WO1996030022A1 Topical ophthalmic formulations comprising an acidic drug, vitamin e tpgs, benzalkonium chloride and caffeine
10/03/1996WO1996030021A1 Azathioprine compositions for colonic administration
10/03/1996WO1996030020A1 Transdermal device for the delivery of alfuzosin
10/03/1996WO1996030013A1 Transmucosal delivery of melatonin for prevention of migraine
10/03/1996WO1996030010A2 Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections
10/03/1996WO1996030008A1 Lidocaine-vasoconstrictor aerosol preparation
10/03/1996WO1996030002A1 Controlled release of molecular components comprising the use of fragmenting and expanding molecules
10/03/1996WO1996030001A1 Method of making a pressure sensitive skin adhesive sheet material
10/03/1996WO1996030000A1 Pharmaceutical composition for transdermic delivery
10/03/1996WO1996029999A1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application
10/03/1996WO1996029998A1 Nanospheres comprising a biocompatible polysaccharide
10/03/1996WO1996029997A1 Soft gelatin capsule with a gelatin shell comprising xanthine derivative
10/03/1996WO1996029996A1 Gelatin capsule with adjusted water activity
10/03/1996WO1996029995A1 Oral 2-methyl-thieno-benzodiazepine formulation
10/03/1996WO1996029994A1 Mechanically stable solid formulations of active substances
10/03/1996WO1996029993A1 Solid delivery form for oral use
10/03/1996WO1996029992A1 Diltiazem controlled release formulation
10/03/1996WO1996029991A1 Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same
10/03/1996WO1996029990A1 Fibrinogen-coated liposomes
10/03/1996WO1996029989A1 Stable protein:phospholipid compositions and methods____________
10/03/1996WO1996029988A1 Topical formulation for local delivery of a pharmaceutically active agent
10/03/1996WO1996029987A1 Reduction of adhesions using controlled delivery of active oxygen inhibitors
10/03/1996WO1996029986A1 Antitussive microcapsules
10/03/1996WO1996029985A1 Butixocort aerosol formulations
10/03/1996WO1996029984A1 Sterile ophthalmological gel preparation applicable in drops and process for producing it
10/03/1996WO1996029975A1 Oil/water mixture composition
10/03/1996WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996WO1996025922A3 Banded prolonged release active agent dosage form
10/03/1996CA2588767A1 Hapten-carrier conjugates for use in drug-abuse therapy
10/03/1996CA2216878A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996CA2216728A1 Azathioprine compositions for colonic administration
10/03/1996CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2216443A1 Intrapulmonary delivery of hematopoietic drug
10/03/1996CA2216278A1 Transdermally administrable medicament with ace inhibitors
10/03/1996CA2215921A1 Gelatin capsules having adjusted water activity
10/03/1996CA2215711A1 Lidocaine-vasoconstrictor aerosol preparation
10/03/1996CA2215256A1 Transdermal device for the delivery of alfuzosin
10/03/1996CA2215255A1 Butixocort aerosol formulations
10/02/1996EP0735122A2 Adhesive base material
10/02/1996EP0734737A2 Particle delivery of particularly therapeutic powdered agents
10/02/1996EP0734730A1 Use of a CGRP antagonist for the treatment of ocular or eyelid pruritis and disesthesies
10/02/1996EP0734729A1 Use of a CGRP antagonist for the treatment of cutaneous erythema of neurogenic origin and so obtained composition
10/02/1996EP0734728A1 Use of a CGRP antagonist for the treatment of lichens and pruritis and composition so obtained
10/02/1996EP0734724A1 A composition for preventing and treating kinetotia syndrome
10/02/1996EP0734722A1 Percutaneous administration patch medicine
10/02/1996EP0734721A2 Method of incorporating drugs into a polymer component of stents
10/02/1996EP0734720A1 Particles based on polyamino-acid(s) for use as carriers for active agents and their processes of preparation
10/02/1996EP0734719A1 Method and device to manufacture aerosols and their use
10/02/1996EP0734710A2 Medicament and support
10/02/1996EP0734448A1 Gene therapy for restenosis using an adenoviral vector
10/02/1996EP0734394A1 Peptide inhibitors of cxc intercrine molecules
10/02/1996EP0734285A1 Deep-bed filter for exterminating micro-organisms and inactivating viruses and its use
10/02/1996EP0734267A1 Aqueous topical compositions
10/02/1996EP0734260A1 Paroxetine tablets and process to prepare them
10/02/1996EP0734257A1 Pharmaceutical compositions for topical use containing (s)-2-(4-isobutylphenyl)propionic acid
10/02/1996EP0734254A1 Adhesive patch for transdermal drug delivery
10/02/1996EP0734253A1 Biphasic capsule formulation
10/02/1996EP0734252A1 Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
10/02/1996EP0734251A1 Method of transmitting a biologically active material to a cell
10/02/1996EP0734250A1 Lipid vesicles containing avocado oil unsaponifiables
10/02/1996EP0734249A1 Novel and improved aminoglycoside formulation for aerosolization
10/02/1996EP0734248A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
10/02/1996EP0734246A1 Cosmetic or dermatological oil-in-water emulsions containing amino acids and inorganic pigments
10/02/1996EP0505474B1 Antiperspirant
10/02/1996EP0489181B1 Solid preparation
10/02/1996EP0480054B1 Percutaneously absorbable composition of morphine hydrochloride
10/02/1996EP0450094B1 Hydrophilic polymer-silicate mineral composite and its use
10/02/1996DE19512181A1 Transdermal applizierbares Arzneimittel mit ACE-Hemmern Transdermally administrable drug with ACE inhibitors
10/02/1996DE19511322A1 Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung Sterile ophthalmic gels containing medium chain triglycerides and processes for their preparation
10/02/1996DE19511131A1 Mechanisch stabile feste Wirkstoffzubereitungsformen Mechanically stable solid preparation of active forms
10/02/1996CN1132479A Mycophenolate mofetil high dose oral suspensions
10/02/1996CN1132478A A novel pharmaceutical for oral administration comprising progresterone and a polyethyelene glycol together with an exipient
10/02/1996CN1132477A Process II
10/02/1996CN1132476A Process I
10/02/1996CN1132475A Composion for releasing essence for nose
10/02/1996CN1132473A Hair styling conmpositions containing a silicone grafted polymer and low level of a volatile hydrocarbon solvent
10/02/1996CN1132467A Substantive antimicrobial phosphates
10/02/1996CN1132212A Method for crystallizing interferon alpha-2
10/02/1996CN1132098A Human leucocyte interferon spray
10/02/1996CN1132097A Health medicine for treatment of cardiopathy and its prodn. method
1 ... 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 ... 2991